Mesenchymal Hamartomas of the Liver: Comparison of Clinicopathologic Features between Cystic and Solid Forms by Chang, Hee Jin et al.
INTRODUCTION
Mesenchymal hamartoma (MH) of the liver is a rare benign
lesion mostly affecting children particularly in the first 2 yr
of life (1), but a few cases have been reported in adults (2). It
is frequently cystic, and consists mainly of mesenchymal
stroma and architecturally abnormal biliary structures with
hepatocyte lobules as a minor component (1, 2). The patho-
genesis of MH has been considered to be aberrant develop-
ment of primitive mesenchyme in the portal tract (3). How-
ever, some recent evidences have raised the possibility of
true neoplasm (4-6) and those are as follows: the balanced
translocation involving chromosome 19q13.4 (4); rare cases
of malignant transformation (5); and aneuploidy in flow
cytometric analysis (6).
The cystic nature of MH is the result of cystic degenera-
tion of myxoid stroma or cystic dilatation of bile ducts (7).
Rarely, solid form of MH containing a larger amount of hep-
atocytes has been documented (8, 9). As for the origin of the
hepatocytes within MH, it has been proposed that they might
be entrapped from the surrounding hepatic lobules or the
actual tumor component aberrantly derived by extension of
the derivatives of the primitive hepatic diverticulum grow-
ing into the septum transversum (3).
In contrast to the typical cystic MH, the clinicopatholog-
ic findings of the solid variant of MH have not been well
characterized. Herein, we summarized 17 MHs including
10 cystic cases and 7 solid variants, and compared the clini-
copathologic features of the solid variant with those of the
typical cystic cases.
MAREIALS AND METHODS
We collected 17 cases of MH of the liver diagnosed in 7
hospitals (Seoul National University, Seoul; Sungkyunkwan
University, Seoul; University of Ulsan, Seoul; Yonsei Univer-
sity, Seoul; Chungnam National University, Daejeon; Kyung-
pook National University, Daegu; and Chonbuk National
University, Chonju, Korea) from 1 January, 1992 to 31 De-
cember, 2002. Originally, twenty-five cases had been diag-
nosed as MH, but eight cases were excluded according to
the result of microscopic revision. The revised diagnosis was
infantile hemangioendothelioma in 3 cases, focal nodular
hyperplasia in 2 cases, polycystic liver disease in 2 cases, and
angiomyolipoma in 1 case. The diagnostic criteria for MH
were based on the overgrowth of mesenchymal stroma and
the proliferation of the architecturally abnormal bile ducts
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Mesenchymal Hamartomas of the Liver: Comparison of 
Clinicopathologic Features between Cystic and Solid Forms
Mesenchymal hamartoma (MH) of the liver is an uncommon benign lesion related
to ductal plate malformation. It is usually cystic and mainly composed of myxoid
mesenchymal tissue with tortuous or cystic bile ducts. In order to characterize the
clinicopathological features of MH, the Korean Gastrointestinal Pathology Study
Group collected a total of 17 MH cases diagnosed in 7 hospitals from 1992 to 2002
and compared the clinicopathologic findings of cystic MH with those of solid variant.
Among the 17 cases, 7 (41%) were solid. The solid form showed a higher serum
level of  -fetoprotein (AFP), the smaller bile ducts, and more frequent proliferation of
vessels. Serum AFP level was related to the amount of hepatocytes. Two of seven
solid cases harbored a larger amount of evenly distributed hepatocytes and prolif-
eration of small duct with focal hepatocyte-bile duct transition. These histologic find-
ings are similar to those of mixed hamartoma. Therefore, the mixed hamartoma
and the MH of both solid and cystic types could be the variants of one disease spec-
trum. And hepatocytes within MH might be rather a genuine tumor component than
entrapped into the tumor. In conclusion, MH can show various clinicopathological
features and recognition of these features will facilitate accurate diagnosis of MH.
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with or without cystic change, accompanied by periductal
collaring of stromal cells (2, 3). In order to confirm the origi-
nal diagnosis and to evaluate the relevant pathologic findings,
eight pathologists reviewed the representative glass slides of
all cases. The gender, age and serum  -fetoprotein (AFP) level
of patients, and size and location of tumor were evaluated by
a review of the medical charts and the pathologic records.
A variety of pathologic findings evaluated were as follows:
the gross finding of MH (cystic or solid) (Fig. 1); the amount
(moderate or abundant) and the nature (myxoid, collagenous
or hyalinized) of mesenchymal stroma; the presence or absence
of duct proliferation and the architecture of bile duct (cys-
tic, tortuous, or small); the amount of hepatocytes (little or
moderate); and the presence or absence of vascular prolifera-
tion. The amounts of stroma and hepatocytes were semiquan-
titatively assessed: little in <10%, moderate in 10-50%,
abundant in >50% of the MH.
Comparison of these various pathologic findings between
cystic and solid MHs were statistically analyzed using the
Mann-Whitney U-test and t-test. A p value of less than 0.05
was considered statistically significant. All statistical analyses
were performed using SPSS-PC software (SPSS, Chicago, IL,
U.S.A.). 
RESULTS
Case summary
Clinical data of 17 cases were summarized in Table 1. There
were 9 females and 8 males. The mean age at diagnosis was
9 yr, ranging from 1 month to 73 yr. Eleven out of 17 patients
(65%) were 2 yr of age or younger and two patients were
adult, 39 and 73 yr old. The MH involved the right lobe of
liver in 10 out of 17 cases (59%), the left lobe in 4 cases (23
%) and both lobes in 3 cases (18%). The majority of the patients
(15 out of 17, 88%) had solitary while two cases had multi-
ple tumors. The mean diameter of MH was 11.4±8.8 cm
(range 2 to 20 cm). In case No. 11 (Table 1), a small MH,
measuring 2 cm in diameter, was incidentally detected in
the liver of a 79-yr-old man during an emergent operation
for diaphragmatic rupture due to traffic accident. It was locat-
ed in the right lobe of liver and was multicystic showing irreg-
Fig. 1. Gross finding of MH. (A) Cystic MH (case 8). (B) Solid MH (case 7).
A B
Case
No.
Gender Nature Number Site
Age 
(yr)
Size
(cm)
AFP
(ng/mL)
1 M 6 Left Solitary 5 Solid 5
2 M 4 Both Multiple -* Solid -
�
3 M 2 Right Solitary 20 Cystic 5
4 F 1 Left Solitary 15 Cystic -
�
5 F 1 Right Solitary 2 Solid 920
6 F 8 Left Solitary 15 Solid -
�
7 F 6 Right Solitary 17 Solid 55
8 M 3 mo. Both Solitary 17 Cystic 286
9 F 1 Right Solitary 10 Cystic 133
10 F 39 Right Solitary 5 Cystic 3
11 M 73 Right Solitary 1 Cystic 5
12 M 2 Right Multiple 10 Cystic 2.2
13 F 1 Right Solitary 14 Cystic -
�
14 M 2 Right Solitary 16 Cystic 5
15 F 2 Right Solitary 18 Cystic 5
16 F 1 Left Solitary 8 Solid 376
17 M 1 mo Both Solitary 9 Solid 755
Table 1. Case summary
*the size was unknown; 
� AFP level was not checked.Mesenchymal Hamartoma of the Liver 65
ularly dilated bile ducts in the fibrous stroma (Fig. 2A). 
Serum AFP had been checked in 13 patients and found to
be elevated in 6 patients, but the AFP elevation in two infant
patients (case No. 8 and No.17) might be physiologic, since
the AFP level do not reach the adult level until 8 months of
age (normal: less than 30 ng/mL at 1 yr of age, less than 15
ng/mL in adult) (10, 11).
Pathologic findings
As the common finding of all MHs, a moderate to abun-
dant amount of mesenchymal stroma containing numerous
bile duct structures of abnormal configuration accompany-
ing periductal collaring of stromal cells constituted the mass
(Fig. 2B). The stroma was myxoid in 9 out of 17 cases (53%)
Fig. 2. Typical histologic feature of MH. (A) Histologic finding of adult case of MH, incidentally found in a 79-yr-old man (case 11) (H&E, ×
40). (B) Myxoid mesenchymal stroma and proliferation of the architecturally abnormal bile ducts with periductal collaring of stromal cells
(H&E, ×40).
A B
Fig. 3. Various histologic features of stroma and bile duct in MH. (A) Myxoid stroma (H&E, ×40). (B) Collagenous stroma (H&E, ×100).
(C) Cystically dilated bile ducts (H&E, ×100). (D, E) Tortuous bile ducts (H&E, ×100 and ×200, respectively). (F) Small bile ducts (H&E,
×200).
A
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(Fig. 3A) and collagenous or hyalinized in 8 cases (47%) (Fig.
3B). Bile ducts were cystic (Fig. 3C) or tortuous in 10 cases
(59%) (Fig. 3D, E) and small in 7 cases (41%) (Fig. 3F). Cys-
tic changes were various in the amount and size, and appeared
in 13 cases (76%) as simply dilated bile ducts, pseudocysts
or as lymphangiomatous structures.
As a minor component of MH, vessels and hepatocytes
were identified. Vascular proliferation was present in 11 out
of 17 cases (65%) and the vessels were small- to medium-
sized veins or capillaries. Hepatocytes were found in cords,
islands or lobules. In 10 cases (59%), proliferation of mal-
formed bile ductule or small bile duct structure was identi-
fied focally at the periphery of hepatocytic islands or lobules,
occasionally ingrowing into the latter (Fig. 4A). Transition
between hepatocytes and bile ducts was also identified focally
in 8 cases (47%) (Fig. 4B). The hepatocytes were largely locat-
ed in the periphery of the hamartoma. However, in two cases
(case No. 7 and No. 17), they were widely distributed with-
in the entire hamartomas.
The amount of hepatocytes was positively correlated with
the serum level of AFP (361.4±352.6 ng/mL in MH with
moderate amount of hepatocytes vs. 4.2±1.3 ng/mL in MH
Fig. 4. Histologic finding of solid MH containing a larger amount of hepatocytes. (A) The bile ducts are ingrowing into hepatocytes (H&E,
×100). (B) Transition between hepatocytes and bile ducts is identified (H&E, ×200).
B A
Parameters
Solid
(n=7)
Cystic
(n=10)
p-value
Age (mean) 4±3 yr 12±24 yr NS
Gender
Female (n=9) 4  5  NS
Male (n=8) 3  5 
Location
Left (n=4) 3 1 NS
Right (n=10) 2 8
Both (n=3) 2 1
Number
Single (n=15) 6 9 NS
Multiple  (n=2) 1 1
Size (mean diameter) 9.3±5.9 cm 12.6±6.1 cm NS
Serum AFP (mean) 422±409.1 ng/mL 55.5±103.5 ng/mL p=0.031
Table 2. Comparison of the clinical data between solid and cystic
forms of mesenchymal hamartoma in liver 
NS, statistically not significant.
Pathologic findings
Case No.
Solid
(n=7)
Cystic
(n=10)
p-value
Stroma amount
Abundant (n=9) 3 6 NS
Moderate (n=8) 4 4
Stroma nature
Myxoid (n=9) 2 7 NS
Collagenous/Hyalinized (n=8) 5 3
Bile ducts
Cystic or tortuous (n=10) 2 8 p=0.04
Small (n=7) 5 2
Proliferation of small bile duct
(+) (n=10) 6 4 NS
(-) (n=7) 1 6
Hepatocyte amount
Moderate (n=9) 5 4 NS
Little (n=8) 2 6
Vascular proliferation
(+) (n=11) 7 4 p=0.013
(-) (n=6) 0 6
Table 3. Comparison of the pathologic findings between solid
and cystic forms of mesenchymal hamartomawith little amount of hepatocytes; p=0.031). The correlation
between the amount of hepatocytes and the serum level of
AFP was also significant in the cystic forms (p=0.025), as
well as in the solid forms (p=0.046).
Comparison of clinicopathologic findings between cystic
and solid mesenchymal hamartomas
Ten cases (59%) were predominantly cystic, whereas 7 cases
(41%) were predominantly solid. Clinical findings of cystic
MH were not significantly different from those of solid MH,
except serum AFP level (Table 2). The AFP level were sig-
nificantly higher in patients with solid MH than in those
with cystic MH (422±409.1 ng/mL vs. 55.5±103.5 ng/
mL, respectively; p=0.031).
In cases of the cystic MH, the cysts were dilated bile ducts
in 5 out of 10 cases (50%), pseudocysts secondary to cystic
degeneration of mesenchymal stroma in 4 cases (40%) or
lymphangiomatous with a lining of attenuated cells in 1 case
(10%).
In the solid variant of MH, the bile ducts were more fre-
quently small (71%), compared to those of the cystic MH
(20%) (p=0.04), and vascular proliferation was also more
frequently identified (100% vs. 40% respectively; p=0.013)
(Table 3). Other pathologic findings including the amount
and the nature of mesenchymal stroma, the ductular prolif-
eration, and the amount of hepatocytes were not significant-
ly different between the cystic and the solid MHs.
DISCUSSION
The term ‘‘mesenchymal hamartoma’’, now widely accept-
ed, was coined by Edmondson in 1956, but before he intro-
duced the term, it had been described under a variety of
names: bile cell fibroadenoma, bile duct fibroadenoma, lym-
phangioma, cavernous lymphangiomatoid tumor, pseudo-
cystic mesenchymal tumor, benign mesenchymoma, and
cystic hamartoma (12). According to the original description
by Edmondson, MH was a cystic mesenchymal lesion, chiefly
composed of connective tissue containing much serous fluid
(12). However, depending upon the amount and nature of
stroma, it may present as a cystic or solid mass. 
Stocker and Ishak described that MHs of the older patients
were more commonly cystic and those of the younger patients
more commonly solid (1), whereas all of 18 childhood cases
in a 35-yr review of DeMaioribus et al. were cystic (7). In
the present study, only two were the adult cases and both
were cystic MH, while 7 out of 15 (47%) child cases were
predominantly solid. These findings are in agreement with
the description of Stocker and Ishak (1), although the cystic
components were less frequent in the present study. In con-
trast to the cases of Cook et al. in which the stromal compo-
nent of childhood MHs was fibrotic with areas of dense hya-
linization and only focal myxoid areas (2), there was no sig-
nificant difference in the stromal component between the
adult and childhood cases and between the cystic and solid
cases in our collection. 
In the present study, some cases of solid MH showed fea-
tures of the so-called ‘‘mixed hamartoma’’ including larger
amount of hepatocyte, ductal proliferation and hepatocellu-
lar-ductal transition. The mixed hamartoma is a very rare
hamartomatous lesion composed of all cellular components
of the normal liver and it shares histologic features of vascu-
larized fibroductular tissue with mesenchymal hamartoma
and focal nodular hyperplasia (13, 14). Rhodes et al. described
that mixed hamartoma could be distinguished from the ordi-
nary cystic MH or focal nodular hyperplasia by the lack of
cystic change, the presence of embryonal hepatocytes with
hepatocellular-bile ductular transformation, and the presence
of the extremely broad fields of ductules and central veins
(13). However, the findings in the present series suggest that
the mixed hamartoma and MH may be in one disease spec-
trum, since there are some overlapping in the histological
findings of both hamartomas in addition to the common
feature of periductal collaring of mesenchymal stroma. Both
hamartomas are likely to be derived from portal tract (3, 13),
but the mixed hamartoma is less differentiated and solid,
whereas the MH is more differentiated and cystic (13). Chan
et al. had suggested that the morphology of MH might be
changed with age as follows: progressive loss of hepatocytes;
degeneration of bile duct epithelium; and cystic change of
the mesenchymal components (15). According to their sug-
gestion, the mixed hamartoma and solid variant of MH may
be the immature forms of the ordinary cystic MH.
It has been traditionally considered that the hepatocytes
within MH are entrapped from the surrounding normal liver
(3). However, when we consider the embryonal feature of
hepatocytes in the mixed hamartoma and the positive corre-
lation between serum AFP level and the amount of hepato-
cytes in solid MH of the present study, some hepatocytes in
MH is suggested to be immature hepatocytes developed as
a components of the lesion rather than entrapped mature
hepatocytes.
The serum levels of AFP in patients with MH were mea-
sured in some previous studies where it was largely within
normal limits (8, 9, 16, 17). But Ito et al. reported that five
out of 7 Japanese cases of MH showed a high serum level of
AFP ranging 3,200 to 6,000 ng/mL, and demonstrated the
immunohistochemical localization of AFP in the proliferat-
ing hepatocytes and bile duct epithelium of MH (9). In the
present study, the elevation of serum AFP level was found
in 6 out of 13 cases (46%), and was more frequently noted
in the predominantly solid MH than in the predominantly
cystic form. This correlation may also support that the hep-
atocytes within the tumor mass are a true component of MH.
In conclusion, MH can show various clinicopathologic
features and recognition of the clinicopathological differences
Mesenchymal Hamartoma of the Liver 67between the typical MH and its variants will facilitate its
accurate diagnosis. 
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